Editorial: Developing combined modality therapy with mitochondria-targeting strategy

Front Oncol. 2023 Jan 6:12:1111724. doi: 10.3389/fonc.2022.1111724. eCollection 2022.

Author

Yong Teng^{1

2}

Affiliations

¹ Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, School of Medicine, Atlanta, GA, United States.
² Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology & Emory University, Atlanta, GA, United States.

No abstract available

Keywords: cancer; combined therapy; mitochondria and disease; targeting strategy; translational sciences.

Publication types

Editorial

Grants and funding